Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07464119) titled 'A Clinical Study of iPSC-Derived Islet Cells for Diabetes Mellitus Therapy' on March 4.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Peking University First Hospital
Condition:
Diabetes Mellitus
Intervention:
Biological: iPSC-derived islet cell
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: March 16, 2026
Target Sample Size: 30
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07464119
Published by HT Digital...